Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @century_tx
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @century_tx
-
Century Therapeutics is honored to join
@QuilHealth and MOBiLion Systems as the three Healthcare Startup finalists for@PhilaPACT's 2020 Enterprise Awards which celebrate innovative life sciences and technology leaders in#Philadelphia. https://bit.ly/2OKH9JJ#biotech#ipscHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Century is honored to be named one of four finalists for the 2019 Emerging Company of the Year Award by
@LifeSciencesPA. Learn about how we’re democratizing cancer care. http://www.centurytx.com#celltherapy#biotechpic.twitter.com/vRzqcxLppw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Century is happy to welcome Joe Jimenez to its Board of Directors and Greg Russotti as its CTO. https://bwnews.pr/2tL9lVv
#celltherapy#biotechpic.twitter.com/f4SC0Ngz5b
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Century Therapeutics CEO Lalo Flores will speak on a panel at the
@WuXi_AppTec Global Forum 2020 focused on Advancing Breakthroughs for Patients Tues at 4:10. https://bit.ly/2NaIuIW#JPM20#AdvancingBreakthroughs4Patients#WuXiGlobalForum2020#CelltherapyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great news for healthcare and business in
#Philadelphia, especially#celltherapy. Thanks to@TechnicallyPHL's@By_paigegross for including Century.https://bit.ly/2ptFYEIHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Century's Carl Burke contributed to a new
#NAMPerspectives paper on risks to avoid on the path to#regulation for cell and gene therapy products. https://doi.org/10.31478/201909d …#celltherapypic.twitter.com/9FLuQS8qmD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our CEO Lalo Flores was honored to join Century's partner Fujifilm
@CellDynamics Friday to celebrate the opening of their 32,000-sq.ft. GMP cell manufacturing facility in Madison. https://bit.ly/2lfyW4H@MadisonStartupspic.twitter.com/wuR1LS7ig6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks for including Century, David!
#celltherapyhttps://twitter.com/DShaywitz/status/1168894674020503552 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
century_tx proslijedio/la je Tweet
.
@century_tx's Chief Strategy Officer Janelle Anderson in conversation with@ldtimmerman on The Long Run#podcast https://soundcloud.com/longrunpodcast/ep49-janelle-anderson …@PhillyBioHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our Chief Strategy Officer Janelle Anderson traced the steps of her path to biotechnology in the latest episode of
@ldtimmerman’s The Long Run podcast https://m.soundcloud.com/longrunpodcast/ep49-janelle-anderson …#WomenInSTEM#CellTherapyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
century_tx proslijedio/la je Tweet
Afternoon innovation panel with
@humanPoC from@century_tx Liz Schwarzbach from@nyscf and Lisa Ricciardi moderated by@LoriDernavich#foundation2019#notamanelpic.twitter.com/KvMExCpK0f
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
century_tx proslijedio/la je Tweet
29July: Which private
#biotech, pharma, and diagnostic/therapeutic technology companies raised the most in financings so far this year? My latest for@GENbio --http://ow.ly/hgvg50vfa54Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
century_tx proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
century_tx proslijedio/la je Tweet
ICYMI: off-the-shelf iPSC company Century Therapeutics debuted last week with $250M from
@LeapsByBayer and Versant. Read why the partners think iPSCs can tackle the stumbling blocks of CAR therapies:http://biocentury.com/bc-extra/financial-news/2019-07-01/versant-bayer-bet-big-ips-cells-tackle-price-efficacy-car- …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
century_tx proslijedio/la je Tweet
.
@century_tx, a Philadelphia-based biotech startup, received $250 million in venture financing to continue developing cellular therapy treatments for cancer.#GreaterHere#InnovatePHL#HealthCarePHL https://on.wsj.com/2YqCI9o pic.twitter.com/dxEXrWPHP5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
century_tx proslijedio/la je Tweet
Let's hear it for
#Philly#Entrepreneur@century_tx launching w/ $250M for Induced Pluripotent#stemcell Platform via@biospace https://www.biospace.com/article/century-therapeutics-launches-with-250-million-to-support-induced-pluripotent-stem-cell-platform/ …#financing#capitalpic.twitter.com/LHMTTTuOB0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
century_tx proslijedio/la je Tweet
Startup Century Therapeutics seeks cancer cures through new type of cellular therapyhttps://www.wsj.com/articles/biotech-startup-century-therapeutics-lands-250-million-in-venture-financing-11561928400 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
century_tx proslijedio/la je Tweet
Century Therapeutics wants to develop off-the-shelf cancer cell therapies. Now it has $250 million in funding behind it.
#startuphttp://ow.ly/fFQe50uSAgBHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
century_tx proslijedio/la je Tweet
We’re partnering with
@century_tx to develop curative therapies for cancer using#iPSCs. Learn more here: https://leaps.bayer.com/about-us/#LeapsbyBayer#DareToLeap#StemCellspic.twitter.com/gHi5l6flw6Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
century_tx proslijedio/la je Tweet
Cancer is one of today’s biggest health concerns and available therapies are limited. Together with Versant Ventures and
@CellDynamics, we are investing USD 250 million to support the development of new treatments. Read more: http://bit.ly/2xlbs0p@LeapsByBayerpic.twitter.com/T7t6DGCh01
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.